OTC Sleep Aids for Older Adults: Understanding the Beers Criteria Warning

The uneasy part about OTC sleep aids for older adults is that the warning is hiding in plain sight. Diphenhydramine and doxylamine sit on ordinary drugstore shelves, often in familiar “PM” products, yet the American Geriatrics Society Beers Criteria lists both as potentially inappropriate for adults 65 and older because of anticholinergic effects and reduced clearance with age.[1] That is not a small-print technicality. It is a safety flag for the person who takes a tablet at 3 a.m., then calls the next morning’s unsteadiness, dry mouth, or fuzzy thinking “just getting older.”

The mismatch becomes sharper when use moves from an occasional bad night to a routine. In a Gerontological Society of America workgroup analysis of National Health and Wellness Survey data, 37% of adults ages 65 to 74 who used OTC sleep aids took them 15 or more days per month; among users age 75 and older, that share was 47%.[1] Those figures do not describe a rare mistake. They describe a common household pattern: a bottle that was bought for short-term relief becoming part of the nightstand.

Many labels tell consumers not to use these products for more than about two weeks unless a clinician says otherwise, and medical centers describe them as short-term options rather than ongoing insomnia treatment.[2] But older adults are often not using them in the tidy way a label imagines. They are using them after bereavement, after surgery, during caregiving stress, after weeks of waking at 2 or 3 a.m., or because the doctor’s appointment is not until next month.

The ingredients to look for are diphenhydramine and doxylamine

Brand names are less reliable than active ingredients. Diphenhydramine is the sedating antihistamine found in many nighttime “PM” products and standalone sleep tablets. Doxylamine is another first-generation antihistamine used in some sleep aids. They can make a person drowsy, which explains why people reach for them. The concern is what else they do, especially in an older body.

A useful first step is to turn the box around and read the Drug Facts panel. If the active ingredient says diphenhydramine HCl, diphenhydramine citrate, or doxylamine succinate, the Beers Criteria warning applies. Combination products deserve extra attention because the sleep ingredient may be tucked inside a pain reliever, cold medicine, or allergy product. For a broader ingredient map, see this guide to OTC sleep medicine ingredients.

Why the same pill can be harder on an older body

Diphenhydramine does not simply disappear when the alarm clock rings. In data summarized by the GSA workgroup, diphenhydramine’s half-life was about 9.2 hours in adults with a mean age of 31.5, compared with about 13.5 hours in adults with a mean age of 69.4.[1] A longer half-life means the drug may still be active the next morning, when a person is walking to the bathroom, making breakfast, managing blood pressure pills, or driving to an appointment.

That lingering effect matters because these drugs are anticholinergic. They block acetylcholine, a chemical messenger involved in memory, attention, urination, bowel function, and other body processes. In practical terms, anticholinergic effects can show up as dry mouth, constipation, urinary retention, blurred vision, confusion, and slowed reaction time. In an older adult who already uses a cane, has nighttime urgency, or takes several prescriptions, a small change in alertness can have a large consequence.

The GSA workgroup tied these concerns to geriatric outcomes that families recognize: confusion, falls, constipation, dry mouth, urinary retention, and next-day impairment.[1] It also cited a nursing home study in which diphenhydramine was associated with psychomotor decline in elderly patients.[1] That is the kind of decline that may not sound dramatic on paper but can look very dramatic at home: slower transfers, missed steps, a shaky turn in the hallway, or a morning when a usually organized person cannot follow the medication routine.

Cognitive concerns are not limited to one sleep product. Harvard Health has warned that drugstore sleep aids with anticholinergic properties may bring more risks than benefits for older adults, including concerns about confusion and memory effects.[3] Johns Hopkins Medicine also cautions that many sleep aids can cause side effects such as dizziness, prolonged drowsiness, and confusion, and advises older adults to speak with a clinician before using them.[4] These warnings do not prove that one occasional tablet causes dementia. They do support a more careful conclusion: adding anticholinergic sedation to an aging brain is not a harmless default.

The hidden problem is anticholinergic overlap

The sleep aid is often not the only anticholinergic medication in the house. The same GSA analysis found that 44% of OTC sleep aid users age 75 and older were also taking other anticholinergic medications.[1] That is where risk becomes less predictable. A person may think of the sleep tablet as separate from bladder medicine, nausea medicine, allergy medicine, antidepressants, or other prescriptions, but the body has to carry the combined burden.

This is why a pharmacist review can be more useful than a quick yes-or-no answer. The question is not only, “Is this product sold without a prescription?” It is, “What else is already slowing alertness, drying secretions, lowering blood pressure, or increasing fall risk?” A daughter cleaning out a parent’s medicine cabinet may find three separate products that all seemed reasonable when bought one at a time.

Why older adults keep using them anyway

Warnings can sound tidy from a distance. Insomnia does not. Someone who has slept badly for six nights may not care about guideline language at midnight. They care that the bed feels hostile, the next day is already ruined, and the little tablet worked once before. That part deserves respect. Relief after a bad night is real relief.

The trouble is that many older adults are not treating a one-night problem. They are treating sleep maintenance insomnia: falling asleep for a while, then waking during the night and staying awake. A long-acting sedating antihistamine is a poor fit for that pattern. It may be taken late, linger into morning, and still fail to address why the person is waking in the first place.

This is the part that gets missed in simple “avoid antihistamines” advice. The behavior continues because the product is available, familiar, and sometimes effective enough to reinforce the habit. It is also easier to buy a bottle than to wait for a sleep evaluation, adjust pain control, address nocturia, taper evening alcohol, manage anxiety, or start a structured insomnia program. Convenience is not the same as safety, but it explains why the bottle stays within reach.

Chronic insomnia should not be managed as nightly sedation

For chronic insomnia, the evidence does not make OTC antihistamines look like a strong treatment. The GSA workgroup notes that insomnia guidelines do not recommend diphenhydramine for chronic insomnia because evidence is limited and safety concerns are meaningful in older adults.[1] Mayo Clinic similarly presents nonprescription sleep aids as short-term options and cautions that older adults may be more likely to experience side effects from them.[2]

There are times when a clinician may decide that short-term use is acceptable for an acute, clearly explained disruption. A few nights after travel, a temporary stressor, or a brief illness is different from most nights of the month. But routine use after 65 should not drift along without a medication review, especially if there has been a fall, a memory scare, urinary trouble, constipation, or new morning fog.

What is safer is not always proven to work better

It is tempting to replace diphenhydramine with a supplement and feel the problem has been solved. That is too neat. Melatonin, magnesium glycinate, and L-theanine may have lower anticholinergic risk than diphenhydramine or doxylamine, but lower risk is not the same as strong evidence for every older adult with insomnia.

Melatonin is the most familiar alternative, and some clinicians discuss low doses such as 0.5 to 1 mg, especially when the issue involves circadian timing rather than simple sedation. But melatonin is a supplement, not an OTC drug regulated the same way as diphenhydramine. Sleep Foundation notes that more than 70% of melatonin products tested had label-dose discrepancies, which makes “take a low dose” harder in practice when the bottle may not contain what the front label suggests.[5]

Magnesium glycinate and L-theanine are also commonly discussed, but the evidence base for meaningful insomnia improvement in older adults is limited. They may be reasonable to ask about, particularly when a clinician knows the person’s kidney function, medication list, and sleep pattern. They should not become the new automatic nightly habit simply because they sound gentler.

This distinction is especially important because supplements and OTC drugs follow different rules. If the choice is between products, the first comparison should be regulatory and safety-related, not just “natural” versus “medicine.” This guide to the difference between OTC drugs and sleep supplements explains why the label format, ingredient verification, and evidence expectations are not the same.

The strongest alternative is usually not another bottle

For persistent insomnia, cognitive behavioral therapy for insomnia, or CBT-I, is the practical center of safer care. It does not sedate the brain. It works on the learned patterns, timing, worry, and behaviors that keep insomnia going. That can include sleep restriction, stimulus control, cognitive work, relaxation strategies, and careful tracking of sleep rather than guessing from memory.

CBT-I asks more of a person than swallowing a pill, which is one reason it can be delayed. It may also require access to a trained clinician, a digital program, or a primary care team willing to help. But it fits the problem better when insomnia has become chronic. The goal is not to knock someone out for a few hours; it is to rebuild sleep in a way that does not add morning impairment.

For a fuller walk-through, start with the CBT-I framework for chronic insomnia. If the immediate question is which nonprescription option matches which sleep problem, use a safety-first comparison such as best OTC sleep aid by sleep problem, and keep the age-specific warnings in view. For non-drug approaches, this evidence-tiered home remedies guide can help separate low-risk routines from claims that are mostly wishful.

A practical safety handoff

The Beers Criteria warning is justified. Diphenhydramine and doxylamine are especially poor long-term choices for adults 65 and older because they can last longer in the body, add anticholinergic burden, worsen next-day function, and interact unpredictably with the rest of a real medication list. The point is not to shame the person who was desperate for sleep. It is to stop treating a risky nightly workaround as if it were ordinary self-care.

• Check the active ingredient, not just the brand name or “PM” wording.
• Look for diphenhydramine or doxylamine in sleep, cold, allergy, and pain products.
• Ask a pharmacist or clinician to check for anticholinergic overlap with prescriptions.
• Avoid drifting into routine use beyond the short-term label window unless a clinician is supervising it.
• Treat ongoing insomnia as a sleep problem to solve, with CBT-I at the center, rather than as a nightly sedation problem to manage.

References

1. Sleep Health and Appropriate Use of OTC Sleep Aids in Older Adults — GSA Workgroup
2. Sleep aids: Understand options sold without a prescription — Mayo Clinic
3. Drugstore sleep aids may bring more risks than benefits — Harvard Health
4. Sleep Aids — Johns Hopkins Medicine
5. Compare Sleep Aids: Understanding the Differences — Sleep Foundation